Ra Capital Management, L.P. 89bio, Inc. Transaction History
Ra Capital Management, L.P.
- $4.58 Billion
- Q2 2025
A detailed history of Ra Capital Management, L.P. transactions in 89bio, Inc. stock. As of the latest transaction made, Ra Capital Management, L.P. holds 19,889,683 shares of ETNB stock, worth $161 Million. This represents 4.27% of its overall portfolio holdings.
Number of Shares
19,889,683
Previous 19,889,683
-0.0%
Holding current value
$161 Million
Previous $145 Million
35.08%
% of portfolio
4.27%
Previous 3.0%
Shares
10 transactions
Others Institutions Holding ETNB
# of Institutions
214Shares Held
162MCall Options Held
299KPut Options Held
1.61M-
Janus Henderson Group PLC London, X020.8MShares$168 Million0.11% of portfolio
-
Suvretta Capital Management, LLC New York, NY14.2MShares$115 Million4.8% of portfolio
-
Deep Track Capital, LP Greenwich, CT9.5MShares$76.8 Million3.31% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.24MShares$66.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.02MShares$56.7 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $376M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...